Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2020 Jan;44(1):1-9.
doi: 10.1080/03630269.2020.1731530. Epub 2020 Mar 16.

Hb S/ β-Thalassemia in the REDS-III Brazil Sickle Cell Disease Cohort: Clinical, Laboratory and Molecular Characteristics

Affiliations
Multicenter Study

Hb S/ β-Thalassemia in the REDS-III Brazil Sickle Cell Disease Cohort: Clinical, Laboratory and Molecular Characteristics

André R Belisário et al. Hemoglobin. 2020 Jan.

Abstract

We described the clinical, laboratory and molecular characteristics of individuals with Hb S (HBB: c.20A>T)/β-thalassemia (Hb S/β-thal) participating in the Recipient Epidemiology and Donor Evaluation Study (REDS-III) Brazil Sickle Cell Disease cohort. HBB gene sequencing was performed to genotype each β-thal mutation. Patients were classified as Hb S/β0-thal, Hb S/β+-thal-severe or Hb S/β+-thal based on prior literature and databases of hemoglobin (Hb) variants. Characteristics of patients with each β-thal mutation were described and the clinical profile of patients grouped into Hb S/β0-thal, Hb S/β+-thal and Hb S/β+-thal-severe were compared. Of the 2793 patients enrolled, 84 (3.0%) had Hb S/β0-thal and 83 (3.0%) had Hb S/β+-thal; 40/83 (48.2%) patients with Hb S/β+-thal had mutations defined as severe. We identified 19 different β-thal mutations, eight Hb S/β0-thal, three Hb S/β+-thal-severe and eight Hb S/β+-thal. The most frequent β0 and β+ mutations were codon 39 (HBB: c.118C>T) and IVS-I-6 (T>C) (HBB: c.92+6T>C), respectively. Individuals with Hb S/β0-thal had a similar clinical and laboratory phenotype when compared to those with Hb S/β+-thal-severe. Individuals with Hb S/β+-thal-severe had significantly lower total Hb and Hb A levels and higher Hb S, white blood cell (WBC) count, platelets and hemolysis markers when compared to those with Hb S/β+-thal. Likewise, individuals with Hb S/β+-thal-severe showed a significantly higher occurrence of hospitalizations, vaso-occlusive events (VOE), acute chest syndrome (ACS), splenic sequestration, blood utilization, and hydroxyurea (HU) therapy.

Keywords: Clinical events; Hb S/β+-thalassemia (Hb S/β+-thal); Hb S/β0-thalassemia (Hb S/β0-thal); sickle cell disease; thalassemia mutation.

PubMed Disclaimer

Conflict of interest statement

Disclosure statement

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article.

Figures

Figure 1.
Figure 1.
Mutations causing β-thal observed in this study. The HBB is depicted with the three exons (1, 2 and 3), two introns (IVS-I and IVS-II), conserved sequences in the 5' and 3' untranslated regions (5'UTR and 3'UTR), and the invariant dinucleotides at the exon-intron junctions of the gene. The vertical lines above or below HBB represent the sites of the different point mutations. The mutations found in the study can be classified into four groups according to their effect on gene function and Hb A production: (A) transcriptional, (B) consensus splice site, (C) cryptic splice site, (D) polyA signal mutations, (E) Splice junction, (F) frameshift and (G) nonsense codon.

Similar articles

Cited by

References

    1. Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet. 2010;376(9757):2018–2031. - PubMed
    1. Figueiredo MS. The compound state: Hb S/β-thalassemia. Rev Bras Hematol Hemoter. 2015;37(3):150–152. - PMC - PubMed
    1. Serjeant GR, Sommereux AM, Stevenson M, et al. Comparison of sickle cell-β 0 thalassaemia with homozygous sickle cell disease. Br J Haematol. 1979;41(1):83–93. - PubMed
    1. Serjeant GR, Serjeant BE, Fraser RA, et al. Hb S-β-thalassemia: molecular, hematological and clinical comparisons. Hemoglobin. 2011;35(1):1–12. - PubMed
    1. Belisario AR, Sales RR, Viana MB. Very mild forms of Hb S/β+-thalassemia in Brazilian children. Rev Bras Hematol Hemoter. 2015;37(3):198–201. - PMC - PubMed

Publication types

MeSH terms